CaridianBCT is actively monitoring the H1N1 influenza virus and has activated its pandemic preparedness plan globally.
LAKEWOOD, Colo.—August 6, 2009— CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies, is actively monitoring the H1N1 influenza virus and has activated its pandemic preparedness plan globally. At this time, the company does not see any impact on its ability to deliver quality products to customers.
CaridianBCT’s Business Continuity Plan includes pandemic preparedness and ensures that it will have the appropriate staffing and capacity to ensure that if an epidemic occurs, the supply of product (both disposable kits and equipment) will be maintained.
CaridianBCT is working globally with organizations such as the AABB Interorganizational Task Force on Pandemic Influenza and the Blood Supply to ensure immediate and direct response to customer responses regarding the H1N1 virus.
CaridianBCT is the leading global provider of innovative technologies and services specializing in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies. The company serves patients through its commitment For Better Blood and Better Lives by developing and commercializing products that serve global customers in the blood banking, therapeutic apheresis and transfusion medicine industries. For more information, visit http://www.caridianbct.com/.
Lisa Hayes, Vice President of Global Marketing and Corporate Communications
Phone: +1 303.231.4201